Status:
COMPLETED
Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
12+ years
Brief Summary
Observational study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases
Eligibility Criteria
Inclusion
- Age of 12 or older and rheumatologic disease
Exclusion
- Hypersensitivity to meloxicam
- Hypersensitivity to other Non-steroidal anti-inflammatory drugs (NSAIDS)
- History of asthma, angioedema or urticaria secondary to NSAIDS
- Pregnancy or lactation
- Recent or current history of peptic ulcer disease, severe renal failure and severe hepatic failure
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
22639 Patients enrolled
Trial Details
Trial ID
NCT02184065
Start Date
January 1 2004
Last Update
July 9 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.